tirzepatide injection time of day Dosage Guide and Chart for Weight Loss Tirzepatide (Zepbound) for weight loss

Participants : 1407 adults with obesity (a BMI of 30 or above) Average age : 47 Gender : 74% women, 26% men Average starting weight : 113kg Average BMI : 39.9 The trial was broken down into three groups: Patients given the Wegovy 7.2mg injection Patients given the Wegovy 2.4mg injection Patients given the placebo All participants were given lifestyle guidance and dietary support to reduce their calorie intake and exercise more

Translation: if your only metric is total body weight reduction at 72 weeks, tirzepatide wins

Consult a healthcare practitioner prior to use if you are taking any prescription medication or have a serious disease, or if you have been instructed to follow a low protein diet

About this article Cite this article Jaswanthika, S., Ranjani, S

Currow, D

Nach dem Curriculum Ernhrungsmedizin der Bundesrztekammer